Convatec Group (FRA:2CVU) FFO


FRA:2CVU Convatec Group PLC FRA:2CVU
77 GF Score
Price €9.80
GF Value €11.76
! 4 Warning Signs
View Full Analysis

What is Convatec Group FFO?

FFO (Funds from operations) only applies to REITs.

FRA:2CVU
77GF Score
Convatec Group PLC FRA:2CVU
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Convatec Group (FRA:2CVU) Overvalued in 2026?

Based on GuruFocus' analysis, Convatec Group stock appears to be undervalued. The current stock price of €9.80 is trading 16.7% below its estimated GF Value™ of €11.76.

Key valuation signals for FRA:2CVU:

  • FFO:
  • GF Value™: €11.76 vs. price of €9.80 (16.7% below fair value)
  • GF Score™: 77/100 with 4 warning signs

No single metric tells the full story. See the FRA:2CVU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Convatec Group Business Description

Address 20 Eastbourne Terrace, 7th Floor, London, GBR, W2 6LG
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
77GF Score

Get the complete analysis for FRA:2CVU

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.80
Price
€11.76
GF Value